XML 12 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2018
Dec. 31, 2017
Assets:    
Cash and cash equivalents $ 36,862 $ 20,214
Investments in securities:    
Fixed maturities, available-for-sale, at fair value (amortized cost: September 30, 2018: $91,336; December 31, 2017: $100,314) 91,827 103,341
Equity securities, at fair value (cost: September 30, 2018: $27,382; December 31, 2017: $26,003) 51,372 47,367
Short-term investments 27,693 23,780
Other investments 11,997 12,032
Total investments 182,889 186,520
Premium and fees receivable 12,588 10,031
Accrued interest and dividends 1,242 1,100
Prepaid expenses and other receivables 7,601 7,730
Property, net 10,454 10,173
Goodwill and other intangible assets, net 10,906 11,357
Other assets 1,459 1,403
Current income taxes receivable 2,575 385
Total Assets 266,576 248,913
Liabilities:    
Reserve for claims 32,375 34,801
Accounts payable and accrued liabilities 27,437 27,565
Deferred income taxes, net 11,223 8,626
Total liabilities 71,035 70,992
Commitments and Contingencies
Stockholders' Equity:    
Preferred stock (1,000 authorized shares; no shares issued) 0 0
Common stock – no par value (10,000 authorized shares; 1,887 and 1,886 shares issued and outstanding as of September 30, 2018 and December 31, 2017, respectively, excluding in each period 292 shares of common stock held by the Company) 0 0
Retained earnings 195,220 161,891
Accumulated other comprehensive income 319 15,945
Total stockholders’ equity attributable to the Company 195,539 177,836
Noncontrolling interests 2 85
Total stockholders' equity 195,541 177,921
Total Liabilities and Stockholders’ Equity $ 266,576 $ 248,913